Safety of biologics for psoriasis patients during the COVID-19 pandemic: the experience from Wuhan, China

Documenti analoghi

• ERCP during the pandemic of COVID-19 in Wuhan, China
  di: An, Ping, et al.
  Pubblicazione: (2020)
• The safety and feasibility of the screening for retinopathy of prematurity assisted by telemedicine network during COVID-19 pandemic in Wuhan, China
  di: Guo, Zheng, et al.
  Pubblicazione: (2021)
• Safety of lymphocytes immunotherapy during the COVID-19 outbreak in Wuhan, China
  di: Chang, Tianli, et al.
  Pubblicazione: (2021)
• Using the COVID-19 to influenza ratio to estimate early pandemic spread in Wuhan, China and Seattle, US
  di: Zhanwei Du, et al.
  Pubblicazione: (2020-09-01)
• Using the COVID-19 to influenza ratio to estimate early pandemic spread in Wuhan, China and Seattle, US
  di: Du, Zhanwei, et al.
  Pubblicazione: (2020)